We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsor Slapped With Warning Letter for Laxity in Clinical Trial Oversight
Sponsor Slapped With Warning Letter for Laxity in Clinical Trial Oversight
February 27, 2013
A warning letter to Solta Medical recently posted to the FDA’s website reveals concerns that the company put patients at risk during three device clinical trials.